HomeNKGN • NASDAQ
add
NKGen Biotech Inc
Previous close
$1.98
Day range
$1.60 - $1.95
Year range
$0.78 - $6.70
Market cap
36.72M USD
Avg Volume
2.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.43M | 51.03% |
Net income | -33.61M | -383.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.13M | -53.38% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 26.00K | -77.78% |
Total assets | 16.48M | 0.92% |
Total liabilities | 75.17M | 409.07% |
Total equity | -58.69M | — |
Shares outstanding | 22.81M | — |
Price to book | -0.74 | — |
Return on assets | -113.15% | — |
Return on capital | 79.43% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -33.61M | -383.68% |
Cash from operations | -6.94M | -26.95% |
Cash from investing | -18.00K | -260.00% |
Cash from financing | -1.80M | -132.78% |
Net change in cash | -8.76M | -29,300.00% |
Free cash flow | -9.36M | — |
About
Founded
2017
Headquarters
Website
Employees
63